Clinical Trial Update: Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT [Phase 3]

View source ↗

Summary

Phase 3 safety evaluation of Prismocitrate 18 in patients receiving continuous renal replacement therapy with regional citrate anticoagulation is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Prismocitrate 18

Snippet

Sponsor: Vantive Health LLC | Conditions: Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) | Phase 3 | Status: RECRUITING